A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/245 (2006.01) A61K 39/21 (2006.01) A61K 39/235 (2006.01) C07K 14/47 (2006.01) C12N 5/10 (2006.01) C12N 15/12 (2006.01) C12N 15/86 (2006.01) C12N 15/861 (2006.01) C12N 15/867 (2006.01) C12N 15/869 (2006.01) A61K 38/00 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2382952
The present invention concerns methods and compositions for treating cancer in a subject. These methods and compositions utilize the activities associated with the N5 gene product, p84N5. p84N5 contains a functional death domain, can interact with the retinoblastoma gene product and is normally localized to the nucleus of cells. Increasing the activity level of p84N5 in cancer cells is beneficial for the treatment of cancer.
L'invention porte sur des procédés et compositions traitement du cancer utilisant les activités associées au produit génique p84N5 du gène N5. Le p84N5 qui contient un domaine létal fonctionnel peut interagir avec le produit génique du rétinoblastome, et est normalement localisé dans le noyau de la cellule. L'accroissement du niveau d'activité de p84N5 dans les cellules cancéreuses s'avère bénéfique pour le traitement du cancer.
Doostzadeh Jaleh
Goodrich David
Yin Shenmin
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Board Of Regents The University Of Texas System
LandOfFree
Induction of programmed cell death by n5 gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of programmed cell death by n5 gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of programmed cell death by n5 gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398381